Research Summary
The gut microbiome refers to the complex and diverse community of microorganisms, including bacteria, viruses, fungi, and other microbes, residing in the gastrointestinal tract of humans and animals. Comprising trillions of microorganisms, the gut microbiome plays a crucial role in various physiological functions, such as digestion, nutrient absorption, and immune system modulation. The composition of the gut microbiome can be influenced by factors like diet, lifestyle, and antibiotic use. Recent research has highlighted its significance in maintaining overall health, impacting not only digestive processes but also playing a role in metabolism, mental health, and immunity. An imbalance in the gut microbiome, known as dysbiosis, has been associated with various health conditions, emphasizing the importance of understanding and maintaining a healthy microbial balance for overall well-being.
According to DIResearch's in-depth investigation and research, the global Gut Microbiome market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Gut Microbiome include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics, Assembly Biosciences, AnimalBiome, Enterome BioScience etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Gut Microbiome. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gut Microbiome market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gut Microbiome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gut Microbiome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gut Microbiome Include:
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
Assembly Biosciences
AnimalBiome
Enterome BioScience
Gut Microbiome Product Segment Include:
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others
Gut Microbiome Product Application Include:
Human
Animal
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Gut Microbiome Industry PESTEL Analysis
Chapter 3: Global Gut Microbiome Industry Porter's Five Forces Analysis
Chapter 4: Global Gut Microbiome Major Regional Market Size and Forecast Analysis
Chapter 5: Global Gut Microbiome Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Gut Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Gut Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Gut Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Gut Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Gut Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Gut Microbiome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Gut Microbiome Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Gut Microbiome Market Overview 1.1 Product Definition and Statistical Scope 1.2 Gut Microbiome Product by Type 1.2.1 Global Gut Microbiome Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Obesity 1.2.3 Inflammatory Bowel Disease (IBD) 1.2.4 Diabetes 1.2.5 Others 1.3 Gut Microbiome Product by Application 1.3.1 Global Gut Microbiome Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Human 1.3.3 Animal 1.4 Global Gut Microbiome Market Revenue Analysis (2019-2030) 1.5 Gut Microbiome Market Development Status and Trends 1.5.1 Gut Microbiome Industry Development Status Analysis 1.5.2 Gut Microbiome Industry Development Trends Analysis 2 Gut Microbiome Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Gut Microbiome Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Gut Microbiome Market Analysis by Regions 4.1 Gut Microbiome Overall Market: 2023 VS 2024 VS 2030 4.2 Global Gut Microbiome Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Gut Microbiome Revenue and Market Share by Region (2019-2024) 4.2.2 Global Gut Microbiome Revenue Forecast by Region (2025-2030) 5 Global Gut Microbiome Market Size by Type and Application 5.1 Global Gut Microbiome Market Size by Type 5.2 Global Gut Microbiome Market Size by Application 6 North America 6.1 North America Gut Microbiome Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Gut Microbiome Market Size by Type 6.4 North America Gut Microbiome Market Size by Application 6.5 North America Gut Microbiome Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Gut Microbiome Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Gut Microbiome Market Size by Type 7.4 Europe Gut Microbiome Market Size by Application 7.5 Europe Gut Microbiome Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Gut Microbiome Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Gut Microbiome Market Size by Type 8.4 China Gut Microbiome Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Gut Microbiome Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Gut Microbiome Market Size by Type 9.4 APAC (excl. China) Gut Microbiome Market Size by Application 9.5 APAC (excl. China) Gut Microbiome Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Gut Microbiome Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Gut Microbiome Market Size by Type 10.4 Latin America Gut Microbiome Market Size by Application 10.5 Latin America Gut Microbiome Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Gut Microbiome Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Gut Microbiome Market Size by Type 11.4 Middle East & Africa Gut Microbiome Market Size by Application 11.5 Middle East & Africa Gut Microbiome Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Gut Microbiome Market Revenue by Key Manufacturers (2020-2024) 12.2 Gut Microbiome Competitive Landscape Analysis and Market Dynamic 12.2.1 Gut Microbiome Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Viome 13.1.1 Viome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Viome Gut Microbiome Product Portfolio 13.1.3 Viome Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Carbiotix 13.2.1 Carbiotix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Carbiotix Gut Microbiome Product Portfolio 13.2.3 Carbiotix Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Ixcela, Inc 13.3.1 Ixcela, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Ixcela, Inc Gut Microbiome Product Portfolio 13.3.3 Ixcela, Inc Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Novome Biotechnologies 13.4.1 Novome Biotechnologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Novome Biotechnologies Gut Microbiome Product Portfolio 13.4.3 Novome Biotechnologies Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Kintai Therapeutics 13.5.1 Kintai Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Kintai Therapeutics Gut Microbiome Product Portfolio 13.5.3 Kintai Therapeutics Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 ProDigest 13.6.1 ProDigest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 ProDigest Gut Microbiome Product Portfolio 13.6.3 ProDigest Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Caelus Health 13.7.1 Caelus Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Caelus Health Gut Microbiome Product Portfolio 13.7.3 Caelus Health Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 LNC Therapeutics 13.8.1 LNC Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 LNC Therapeutics Gut Microbiome Product Portfolio 13.8.3 LNC Therapeutics Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Assembly Biosciences 13.9.1 Assembly Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Assembly Biosciences Gut Microbiome Product Portfolio 13.9.3 Assembly Biosciences Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 AnimalBiome 13.10.1 AnimalBiome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 AnimalBiome Gut Microbiome Product Portfolio 13.10.3 AnimalBiome Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Enterome BioScience 13.11.1 Enterome BioScience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Enterome BioScience Gut Microbiome Product Portfolio 13.11.3 Enterome BioScience Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Gut Microbiome Industry Chain Analysis 14.2 Gut Microbiome Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Gut Microbiome Typical Downstream Customers 14.4 Gut Microbiome Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support